Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
December 13, 2023 16:06 ET
|
Codexis, Inc.; Aldevron
REDWOOD CITY, Calif. and FARGO, N.D., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with...
Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
December 13, 2023 16:05 ET
|
Codexis, Inc.
Milestone enables Codexis engineers to model the manufacturing process for RNAi therapeutics Company remains on track to initiate pre-commercial customer testing in 2024 REDWOOD CITY, Calif., Dec. ...
Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing
December 11, 2023 07:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, hosted a virtual Key Opinion Leader (KOL) event on Friday, December 8,...
Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023
November 28, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a virtual key opinion leader (KOL) event...
Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference
November 14, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the 35th Annual Piper Sandler...
Codexis Reports Third Quarter 2023 Financial Results
November 02, 2023 16:05 ET
|
Codexis, Inc.
Company Remains on Track to Demonstrate Gram-Scale Synthesis with ECO Synthesis™ Platform for RNAi Therapeutics Production by End of Year Strong Financial Position Enables Projected Runway to...
Codexis to Participate in Upcoming Healthcare Conferences
October 31, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in four upcoming investor...
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
October 27, 2023 15:35 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
October 26, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
Codexis to Report Third Quarter 2023 Financial Results on November 2
October 19, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third...